Harvey, B S <br/><br/>
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model.  [electronic resource] 

 -  Cytokine  Feb 2014 
 - 236-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0023 
<br/><br/><label>Standard No.: </label>10.1016/j.cyto.2013.10.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Arachidonic Acids--pharmacology<br/>Blotting, Western<br/>Caco-2 Cells<br/>Cannabidiol--pharmacology<br/>Cell Membrane Permeability--drug effects<br/>Electric Impedance<br/>Endocannabinoids--pharmacology<br/>Epithelial Cells--drug effects<br/>Epithelium--drug effects<br/>Humans<br/>In Vitro Techniques<br/>Interleukin-17--adverse effects<br/>Interleukin-1beta--pharmacology<br/>Intestinal Mucosa--drug effects<br/>Ligands<br/>Matrix Metalloproteinases--metabolism<br/>Models, Biological<br/>Polyunsaturated Alkamides--pharmacology<br/>Tumor Necrosis Factor-alpha--pharmacology